Effect of a combination of calorie-restriction therapy and Lingguizhugan decoction on levels of fasting blood lipid and inflammatory cytokines in a high-fat diet induced hyperlipidemia rat model  by Yuanyuan, Wang et al.
TOPIC
JTCM |www. journaltcm. com April 15, 2015 |Volume 35 | Issue 2 |
Online Submissions: http://www.journaltcm.com J Tradit Chin Med 2015 April 15; 35(2): 218-221
info@journaltcm.com ISSN 0255-2922
© 2015 JTCM. All rights reserved.
EXPERIMENTAL STUDY
Effect of a combination of calorie-restriction therapy and Linggui-
zhugan decoction on levels of fasting blood lipid and inflammatory
cytokines in a high-fat diet induced hyperlipidemia rat model
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Abstract
OBJECTIVE: To combine calorie-restriction therapy
(CRT) with Traditional Chinese Medicine (TCM) us-
ing Lingguizhugan Decoction and note the effects
on expression of inflammatory cytokines [tumor ne-
crosis factor (TNF)-α, high-sensitivity C-reactive pro-
tein (hs-CRP), interleukin (IL)-6] in high-fat-diet in-
duced hyperlipidemia in rats.
METHODS: Forty rats were divided randomly and
equally into four groups: control group A (regular
feeding for 5 weeks); model group B (high-fat diet
for 5 weeks), calorie-limited group C (high-fat diet
for 5 weeks) and TCM calorie-limit group D
(high-fat diet for 5 weeks). After modeling, groups
C and D were fasted for 3 days: group C with simple
fasting, and group D with TCM fasting. The motion
as well as changes in color, body weight, food in-
take, plasma lipids [low-density lipoprotein-choles-
terol (LDL-C), high-density lipoprotein-cholesterol,
total cholesterol (TC) and triglyceride (TG) along
with TNF-α, hs-CRP and IL-6] were measured before
and after intervention.
RESULTS: Modeled rats were established after five
weeks. After 3 days of fasting, compared with
group B, blood lipid levels (TG, TC, LDL-C) of groups
C and D decreased dramatically. Those of group D
decreased more obviously than those of group C.
However, the values of TNF-α, hs-CRP and IL-6
showed no obvious difference between each of the
three treatment groups.
CONCLUSION: CRT can reduce fasting blood lipid
levels in rats, but not by reducing the levels of in-
flammatory cytokines.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Hyperlipidemia is an independent risk for atherosclero-
sis and is the pathologic basis of cardiovascular and
cerebrovascular diseases. In recent years, there has been
an improvement in people's living standards. Con-
sumption of high-calorie, high-fat diets and less exer-
cise have led to a higher incidence of obesity, hyperten-
sion, diabetes mellitus (DM), hyperlipidemia, coronary
heart disease and cerebrovascular diseases.1,2 Strategies
for controlling diets and improving lifestyle have be-
come a necessary means for the treatment of obesity
and related metabolic disorders.
Calorie-restriction therapy (CRT) has been demonstrat-
ed to decrease body weight, improve insulin resistance,
and regulate immune disorders. Studies have also
shown that CRT is effective against metabolic diseases.1,
3 Through long-term clinical experiments,4 our research
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team found that pure CRT had lipid-lowering effects
in hyperlipidemic patients but, during treatment,
many patients felt hungry and weak, and that their
tongues were significantly thicker after treatment.
We added Lingguizhugan Decoction (LGZGD) to
CRT to create Traditional Chinese Medicine
(TCM)-CRT. This new "hybrid" therapy not only low-
ered lipid profiles in blood, it also reduced the preva-
lence of metabolic-related factors and their side effects.
We hypothesized that the mechanism of action of these
effects may involve vascular inflammatory cytokines,
and wished to test our theory in animals, hence the
study we describe here.
MATERIALS ANDMETHODS
Ethical approval of the study protocol
The study protocol was approved by the Ethics Com-
mittee of the First Affiliated Hospital (Sun Yat-Sen
University, Guangzhou, China).
Animals and diets
Male Wistar rats [specific pathogen-free; 8 weeks; (245
± 8) g] were purchased from the Experimental Animal
Center of Guangdong Province [certificate SCXK
(Guangdong) 2009-0011].
All rats lived in their own cage. They were placed in a
room with a 12-h light-dark cycle and had free access
to food and water. The basic diet and high-fat diet
were purchased from Guangdong Province Animal Ex-
periments (Guangdong, China). The high-fat diet con-
tained 55% more fat than a normal diet (15% lard,
21% sucrose, 9% egg-yolk powder, 0.5% bile salts).
Drugs and reagents
LGZGD comprising Fuling (Poria), Guizhi (Ramulus
Cinnamomi), Baizhu (Rhizoma Atractylodis Macrocepha-
lae), and stir-frying with liquid adjuvant Gancao (Ra-
dix Glycyrrhizae) in the proportion 4∶3∶2∶2 was ob-
tained from 999 Medicine Group (Shenzhen, China).
Assay kits for tumor necrosis factor (TNF)-and inter-
leukin (IL)-6 were obtained from Ray Biotech (Atlan-
ta, GA, USA). An assay kit for high-sensitivity C-reac-
tive protein was purchased from Millipore (Bedford,
MA, USA). A Microplate Reader (Sunrise ™; Tecan,
Männedorf, Switzerland), an ultrapure water system
for trace organic analyses (Yee Young Enterprises, Nan-
jing, China) and a Thermostatic Incubator (Jiangnan
Instrument Factory, Ningbo, China) were also pur-
chased.
Doses of LGZGD
Doses of LGZGD were based on those stated in the
Chinese Pharmacopoeia.5We determined the daily dos-
es for adults according to a mean adult body weight of
60 kg as: Fuling (Poria) 12 g, Guizhi (Ramulus Cinna-
momi) 9 g, Baizhu (Rhizoma Atractylodis Macrocepha-
lae) 6 g, and stir-frying with liquid adjuvant Gancao
(Radix Glycyrrhizae) 6 g.
Grouping and feeding of the rats
First, rats were allowed to adapt to a normal diet for
one week. Rats were then divided into four groups
(A-D) of ten in a 1∶1∶1∶1 ratio randomly using Mat-
lab software. Group-A rats were fed a normal diet and
the other three groups were fed a high-fat diet for five
weeks. We evaluated the modeling effects at the fifth
weekend.
After modeling, groups A and B were administered the
original diet for three days. Group C underwent simple
restriction of calorie intake for three days (i.e., no food,
free access to water, and gavage using physiologic
(0.0%) saline (9 mg/100 g) every day). Group D un-
derwent calorie restriction and LGZGD administra-
tion for three days [no food, free access to water, and
gavage with LGZGD (9 mg/100 g) every day].
Measurements
General condition of rats before and after treatment:
motion as well as changes in color, weight, and food in-
take of rats was recorded. We measured the blood lipid
profiles of all rats at the fifth weekend as well as before
and after restriction of calorie intake. After restriction
of calorie intake and an overnight fast, 3 mL of blood
was obtained from the tail vein. Blood was centrifuged
at 1000 × g for 10 min at room temperature. Serum
was separated from plasma and sent (as 1-mL samples)
to Affiliated Hospital Laboratory for determination of
levels of triglycerides (TG), total cholesterol (TC),
high-density lipoprotein-cholesterol (HDL-C), low-
density lipoprotein-cholesterol (LDL-C) and hs-CRP.
The remaining 2-mL samples were sent to Sun Yat-
Sen Center for measurement of levels of inflammatory
factors.
TNF-α and IL-6
According to a series of standard concentrations and
the corresponding values of optical density at 450 nm
(OD450) we created a TNF-α standard curve using Ori-
gin 7.5 software (OriginLab, Northampton, MA,
USA) to obtain the equation:
Y = 2.1637 + (0.025742-2.16372)/(1 + (X/68212) 0.82886),
whereY is OD450 value and X is the TNF-α standard
concentration.
We followed an identical procedure to an equation for
IL-6:
Y = 5.0013 + (﹣0.012815-5.0013)/(1 + (X/36451) 0.93208),
where Y is OD450 value and X is the IL-6 standard con-
centration.
Using the standard curves, we could obtain the values
of the samples in pg/mL at an absorbance of 450 nm.
Statistical analyses
SPSS v18.0 (IBM, Armonk, NY, USA) was used for
statistical analyses. Measurement data for mean ± stan-
dard deviation ( xˉ ± s), and the Student's t-test was
used to compare between the two groups. Multiple sets
of single-factor analysis of variance were used to com-
paremultiple groups.P≤0.05was considered significant.
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RESULTS
General conditions
No deaths were observed in groups A and C. However,
one rat died in group B and one rat died in group D.
The rat from group B started to fast without an obvi-
ous reason in the fourth week of the experiment, start-
ed to look peaky gradually, and then died. Another rat
in group D died for no obvious reason in the fifth
week before calorie intake-limiting treatment. We took
blood samples from this rat for analyses. Thirty-eight
rats were assessed in total.
In the first four weeks, there was no difference in food
intake, activity or color between rats in groups A-D.
However, after the fourth week, the activities and food
intake, as well as the colors of rats from groups B-D
rats, became worse than those of group A. After three
days of treatment, rats from group C showed low activi-
ty and a more yellowish color than rats of group B, but
rats of group D showed much better activity and color
than those of group C.
Body weight
At week-5, the body weight of the control group dem-
onstrated a linear upward trend. However, in groups
B-D, body weight began to decline in week-4 (P <
0.01) and rats looked anorexic. However, between the
two calorie-restriction groups, a significant difference
in body weight was not observed (P > 0.05). After calo-
rie restriction, rats in group C also exhibited anorexia,
but group-D rats became stronger than group-C rats
(Table 1).
Changes in blood lipid levels
At the fifth weekend, serum levels of TG and cholester-
ol of the other three groups were significantly higher
than those of group A (P < 0.01), but there were no
significant differences in levels of HDL-C or LDL-C
(P > 0.05). After three days of calorie restriction, levels
of TG, cholesterol, HDL-C and LDL-C of groups C
and D were significantly lower than those of group B
(P < 0.01). Also, levels of TG, cholesterol, HDL-C and
LDL-C of group D were reduced further than those of
group C (P < 0.01) (Table 2).
Comparison of levels of TNF-α, hs-CRP and IL-6
Before CRT, compared with the control group, levels
of TNF-, hs-CRP and IL-6 of groups B-D were in-
creased significantly (P < 0.05). However, after CRT,
compared with the model group, levels of TNF- and
hs-CRP of groups C and D showed no significant dif-
ferences, and even the IL-6 levels of these two groups
showed a decreasing trend but without significant dif-
ferences between them, or between them and the mod-
el group (P > 0.05) (Table 3).
DISCUSSION
The present study showed that CRT and TCM-CRT
can reduce serum lipid levels (TG, cholesterol, LDL-C,
HDL-C) significantly and also the body weight of rats.
Group-C rats showed fatigue, drowsiness and lethargy,
but group-D rats treated with LGZGD showed none
of these features, and even exhibited better activity and
fur gloss than group-C rats.
CRT can improve hyperlipidemia significantly. Howev-
er, TCM-CRT not only elicited better effects, but also
reduced the side effects of CRT, so what was the thera-
peutic mechanism? Taking into account the close corre-
lation of hyperlipidemia and inflammatory factors, we
Group
A
B
C
D
n
10
9
10
9
First Day
196±10
202±12
205±9
197±11
First weekend
225±16
230±18
222±12
228±15
Third weekend
254±25
255±27
242±31
251±38
Fifth weekend
275±34a
292±56a
305±57a
309±65a
After fasting
269±48b
301±55b
289±64b
281±70b
Notes: A: control group (standard food for 5 weeks); B: model group (high-fat diet for 5 weeks); C: intervention group (high-fat diet for 5
weeks); D: intervention group (high-fat diet for 5 weeks). Compared with the first day of this group, aP < 0.05; compared with the control
group, bP < 0.01.
Table 1 Comparison of the body weight of rats between the four groups (g)
Group
A
B
C
D
n
10
9
10
9
TC
1.622±0.250
2.082±0.380a
1.181±0.301b
1.383±0.275b
TG
1.062±0.461
1.660±0.553a
0.943±0.212c
0.861±0.184b
HDL-C
0.773±0.090
0.854±0.073a
0.543±0.103c
0.584±0.101b
LDL-C
0.252±0.052
0.500±0.152a
1.165±0.064b
0.193±0.047b
Notes: A: control group (standard food for 5 weeks); B: model group (high-fat diet for 5 weeks); C: intervention group (high-fat diet for 5
weeks); D: intervention group (high-fat diet for 5 weeks). TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein-choles-
terol; HDL-C: high-density lipoprotein-cholesterol. Compared with group A, aP < 0.01; compared with group B, cP < 0.05; compared
with group B, bP < 0.01.
Table 2 Comparisons of lipid levels between the four groups (mmol/L)
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studied the mechanism of action of this treatment.
However, after treatment, levels of TNF-α, hs-CRP,
and IL-6 in groups C and D showed no significant im-
provement than before treatment (P ≥ 0.05). Hence,
there was no significant correlation between TCM-
CRT and anti-inflammatory effects.
Previously, we undertook another study focusing on
CRT in insulin-resistant rats.2 We discovered that
blood glucose and fasting insulin levels were improved
after TCM-CRT, and that peroxisome proliferator-acti-
vated receptor (PPAR)-γ activity was also inhibited.
TCM-CRT might inhibit PPAR-γ activity to improve
insulin resistance. PPAR-γ is a key factor of adipocyte
differentiation, and adipocyte differentiation may have
played a key part in our study. Excessive activation of
PPAR-γ expression in adipose tissue and fat cells might
be involved in obesity.6-8 Hence, inhibition of PPAR-γ
activity in TCM-CRT may be based on inhibition of
the differentiation of fat cells.9-11
We have found that, in clinical trials, CRT can signifi-
cantly improve hyperlipidemia, early DM, insulin resis-
tance and other related metabolic disorders, but its
mechanism of action has not have been explored until
now. Comprehensive experiments in two animal stud-
ies have shown that the mechanism underlying this ef-
fect may not reduce the expression of inflammatory fac-
tors in the body,2,6 but might inhibit the differentiation
of fat cells. After this treatment, patients changed to
eating a healthy diet. We noted the blood levels of glu-
cose and lipids did not rebound. This phenomenon
may also have been due to reactivation of the differenti-
ation of fat cells.11-13 Calorie restriction may complete
the entire process of apoptosis and neogenesis in the
body. The more "comfortable" feeling in the body after
treatment may be associated with this correlation.13-15
Despite our interesting observations, more clinical and
animal studies are needed to support these findings.
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